Literature DB >> 10613358

Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells.

N Uchida1, T Otsuka, H Shigematsu, M Maeda, Y Sugio, Y Itoh, Y Niho.   

Abstract

The maintenance of telomere length is crucial for the survival of cells. Recently, genes for proteins that consist of human telomerase have been cloned and the results have indicated a close relationship between telomerase activity and its gene expression. We studied the mRNA expression of the telomerase-associated genes, hTERT and TEP1, in hematopoietic cells in order to clarify the relation between them and telomerase activity using semiquantitative RT-PCR. In polymorphonuclear cells and monocytes isolated from peripheral blood, which had no detectable telomerase activity, no hTERT mRNA expression was seen. On the other hand, lymphocytes and CD34-positive cells both demonstrated hTERT mRNA expression. TEP1 mRNA was detected in all samples, showing no differential expression. We then assessed hTERT and TEP1 mRNA expression in CD34-positive cells cultured in vitro with growth factors. After 4 weeks of culture, all the cells showed myeloid differentiation and the telomerase activity was downregulated. hTERT mRNA was expressed in CD34-positive cells, but was downregulated in 4-week-cultured cells. TEP1 showed no apparent differential expression. We conclude that hTERT mRNA expression is downregulated in accordance with telomerase downregulation during the course of myeloid differentiation, which suggests that it plays a crucial role in the expression of enzyme activity, while TEP1 has a much smaller role to play, if any.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10613358     DOI: 10.1016/s0145-2126(99)00149-6

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

1.  Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.

Authors:  Konstantia I Pavlaki; Maria-Christina Kastrinaki; Michail Klontzas; Maria Velegraki; Irene Mavroudi; Helen A Papadaki
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

Review 2.  Is telomerase a viable target in cancer?

Authors:  C M Buseman; W E Wright; J W Shay
Journal:  Mutat Res       Date:  2011-07-23       Impact factor: 2.433

3.  Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study.

Authors:  S L Bernhardt; M K Gjertsen; S Trachsel; M Møller; J A Eriksen; M Meo; T Buanes; G Gaudernack
Journal:  Br J Cancer       Date:  2006-10-24       Impact factor: 7.640

4.  DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts.

Authors:  Laura A Richards; Ashu Kumari; Kathy Knezevic; Julie Ai Thoms; Georg von Jonquieres; Christine E Napier; Zara Ali; Rosemary O'Brien; Jonathon Marks-Bluth; Michelle F Maritz; Hilda A Pickett; Jonathan Morris; John E Pimanda; Karen L MacKenzie
Journal:  Haematologica       Date:  2019-08-14       Impact factor: 9.941

Review 5.  Vaccine therapy in non-small-cell lung cancer.

Authors:  Carol Albright; Jennifer Garst
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.945

6.  De novo assembly and characterization of the Chinese three-keeled pond turtle (Mauremys reevesii) transcriptome: presence of longevity-related genes.

Authors:  Huazong Yin; Liuwang Nie; Feifei Zhao; Huaxing Zhou; Haifeng Li; Xianmei Dong; Huanhuan Zhang; Yuqin Wang; Qiong Shi; Jun Li
Journal:  PeerJ       Date:  2016-05-24       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.